SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 20th, 2020 • Genetic Technologies LTD • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 20th, 2020 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July 16, 2020, between Genetic Technologies Limited, an Australian corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).